Novavax vaccine 51 percent effective against South African COVID-19 variant: study | The Hill: Healthcare Policy

A study published in the New England Journal of Medicine on Wednesday found that the Novavax coronavirus vaccine is 51 percent effective against the South African COVID-19 variant.The study of the American-made vaccine was conducted in South Africa...